# 42 CFR 428.201 Calculation of the total rebate amount to be paid by manufacturers.

42 CFR 428.201 Calculation of the total rebate amount to be paid by manufacturers., “Calculation of the total rebate amount to be paid by manufacturers”, is a CFR section of [42 CFR Part 428, Subpart C—Determination of the Rebate Amount for Part D Rebatable Drugs](https://ontology.bommaritollc.com/id/01a0f0b4-288e-7462-a9ec-dda67dbe1a37); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb20e763d01>

Within: [Title 42—Public Health](https://ontology.bommaritollc.com/id/01a0f0b4-250a-76eb-a6f4-ef896ca65429) › [42 CFR Chapter IV—CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f0b4-26ab-75ee-82a3-d67c7d7493e9) › [42 CFR Chapter IV, Subchapter B—MEDICARE PROGRAM](https://ontology.bommaritollc.com/id/01a0f0b4-26d0-77b0-a9cc-8ca65af16a4c) › [42 CFR Part 428—Medicare Part D Drug Inflation Rebate Program](https://ontology.bommaritollc.com/id/01a0f0b4-2c85-77e9-adf9-e20b95824ab7) › [42 CFR Part 428, Subpart C—Determination of the Rebate Amount for Part D Rebatable Drugs](https://ontology.bommaritollc.com/id/01a0f0b4-288e-7462-a9ec-dda67dbe1a37)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 42 CFR 428.201](https://ontology.bommaritollc.com/id/01a0f0b4-49c6-72ee-bb86-118e5a46eaf6)
- `eli:cites`:
  - [42 CFR Part 428—Medicare Part D Drug Inflation Rebate Program](https://ontology.bommaritollc.com/id/01a0f0b4-2c85-77e9-adf9-e20b95824ab7)
  - [42 CFR 428.101 Identification of Part D rebatable drugs.](https://ontology.bommaritollc.com/id/01a0f0b4-49c1-765f-8744-063e522fd9bd)
  - [42 CFR 428.202 Calculation of the per unit Part D rebate amount.](https://ontology.bommaritollc.com/id/01a0f0b4-49c6-72ee-bb86-1190017c6cb5)
  - [42 CFR 428.203 Determination of the total number of units dispensed under Part D.](https://ontology.bommaritollc.com/id/01a0f0b4-49c7-7037-92d2-96c9e4d41011)
  - [42 CFR 428.204 Treatment of new formulations of Part D rebatable drugs.](https://ontology.bommaritollc.com/id/01a0f0b4-49c9-7459-815e-086d5ee50385)
  - [42 CFR 447.502 Definitions.](https://ontology.bommaritollc.com/id/01a0f0b4-4ee1-70d5-9436-a676a041b1dd)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title42-vol1](https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb19bbbf032)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0b4-6d19-70c6-81c9-12c071d62f84)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d1-969f-7093-8439-499f23886294)
  - [evidence from https://www.govinfo.gov/link/cfr/42/428?sectionnum=201&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-fe32-70b0-9c4c-c06bde0b34ca)
- `schema:isPartOf`: [42 CFR Part 428, Subpart C—Determination of the Rebate Amount for Part D Rebatable Drugs](https://ontology.bommaritollc.com/id/01a0f0b4-288e-7462-a9ec-dda67dbe1a37)
- `schema:legislationIdentifier`: 42 CFR 428.201
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Calculation of the total rebate amount to be paid by manufacturers
- `schema:url`: [https://www.govinfo.gov/link/cfr/42/428?sectionnum=201&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/42/428?sectionnum=201&year=mostrecent&link-type=details)
- `skos:prefLabel`: 42 CFR 428.201 Calculation of the total rebate amount to be paid by manufacturers.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/42/428?sectionnum=201&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title42-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (7; `eli:cites`):
  - [42 CFR 428.204 Treatment of new formulations of Part D rebatable drugs.](https://ontology.bommaritollc.com/id/01a0f0b4-49c9-7459-815e-086d5ee50385)
  - [42 CFR 428.301 Reducing the rebate amount for Part D rebatable drugs currently in shortage.](https://ontology.bommaritollc.com/id/01a0f0b4-49cc-731e-bcf3-123b463bd5a6)
  - [42 CFR 428.302 Reducing the rebate amount for certain Part D rebatable drugs when there is a severe supply chain disruption.](https://ontology.bommaritollc.com/id/01a0f0b4-49cd-7147-99bc-99c644232dcc)
  - [42 CFR 428.303 Reducing the rebate amount for generic Part D rebatable drugs likely to be in shortage.](https://ontology.bommaritollc.com/id/01a0f0b4-49cf-75a3-8bc8-3b7f2c95f994)
  - [42 CFR 428.401 Rebate Reports and reconciliation.](https://ontology.bommaritollc.com/id/01a0f0b4-49d2-7423-bf89-c3c0d65e4ffb)
  - [42 CFR 428.403 Suggestion of Error.](https://ontology.bommaritollc.com/id/01a0f0b4-49d5-72a1-a0d4-61ea1fee2017)
  - [42 CFR 428.500 Civil money penalty notice and appeals procedures.](https://ontology.bommaritollc.com/id/01a0f0b4-49d9-73aa-8ca8-159c8d5b9610)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb20e763d01.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb20e763d01.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb20e763d01.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb20e763d01)
Cite as: 42 CFR 428.201 Calculation of the total rebate amount to be paid by manufacturers.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f0b4-49c4-77ea-9dcb-3bb20e763d01
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
